相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2
Marc Humbert et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
John Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort
Els Vandecasteele et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
Sean Gaine et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis
Daniel Dumitrescu et al.
HEART (2017)
Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China
Jiuliang Zhao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study
Abhishek Gadre et al.
LUNG (2017)
Cardiovascular magnetic resonance in systemic sclerosis: Pearls and pitfalls
Sophie I. Mavrogeni et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension A Comparison of Demographic, Hemodynamic, and SRI Characteristics and Outcomes
Sheila Ramjug et al.
CHEST (2017)
High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center
Alfredo Guillen-Del Castillo et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
Kathleen Morrisroe et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
Kathleen Morrisroe et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre
Tomas Soukup et al.
RHEUMATOLOGY (2016)
Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis
Adriana Stamm et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Skin Telangiectasia and the Identification of a Subset of Systemic Sclerosis Patients With Severe Vascular Disease
Charlotte Hurabielle et al.
ARTHRITIS CARE & RESEARCH (2016)
Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study
Kathleen Morrisroe et al.
BMC PULMONARY MEDICINE (2016)
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol
Alicia Calderone et al.
BMJ OPEN (2016)
Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension
Matthew R. Lammi et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Vincent Sobanski et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction A Comprehensive Single-Center Experience
Catherine H. Miele et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Lung Transplant in Patients with Scleroderma Compared with Pulmonary Fibrosis Short- and Long-Term Outcomes
Maria M. Crespo et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study
Christopher R. Pasarikovski et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Exercise echocardiography for the assessment of pulmonary hypertension in systemic sclerosis: a systematic review
Rui Baptista et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
Paul M. Hassoun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)
Ioana R. Preston et al.
CIRCULATION (2015)
The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress
Edmund M. T. Lau et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis
C. Corallo et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2015)
Registry of the Spanish Network for Systemic Sclerosis Survival, Prognostic Factors, and Causes of Death
C. P. Simeon-Aznar et al.
MEDICINE (2015)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
N. Galie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry
Monique Hinchcliff et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Christian Nagel et al.
ARTHRITIS RESEARCH & THERAPY (2015)
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
Yanjie Hao et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Survival of Adults With Systemic Sclerosis Following Lung Transplantation A Nationwide Cohort Study
Elana J. Bernstein et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
Mike O. Becker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
J. Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Unique Predictors of Mortality in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in the REVEAL Registry
Lorinda Chung et al.
CHEST (2014)
Anticoagulation and Survival in Pulmonary Arterial Hypertension Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
Karen M. Olsson et al.
CIRCULATION (2014)
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study
Vivien M. Hsu et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Survival and Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry
Lorinda Chung et al.
ARTHRITIS CARE & RESEARCH (2014)
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study
Scott H. Visovatti et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients
Ami A. Shah et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Borderline Mean Pulmonary Artery Pressure in Patients With Systemic Sclerosis: Transpulmonary Gradient Predicts Risk of Developing Pulmonary Hypertension
Christopher J. Valerio et al.
ARTHRITIS AND RHEUMATISM (2013)
Survival and Prognostic Factors in Systemic Sclerosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis
Guillaume Lefevre et al.
ARTHRITIS AND RHEUMATISM (2013)
Functional implications of IgG anti-endothelial cell antibodies in pulmonary arterial hypertension
Steven J. Arends et al.
AUTOIMMUNITY (2013)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Survival after lung transplantation in systemic sclerosis. A systematic review
Irfan Y. Khan et al.
RESPIRATORY MEDICINE (2013)
Epidemiology and Risk Factors for Pulmonary Hypertension in Systemic Sclerosis
Aaliya Yaqub et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry
Sangmee Bae et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma
Hanadi Dib et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome
Scott W. Graf et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2012)
Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
Ekkehard Gruenig et al.
ARTHRITIS RESEARCH & THERAPY (2012)
N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study
Vivek Thakkar et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
Gene-Siew Ngian et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL Identifying Systemic Sclerosis as a Unique Phenotype
Lorinda Chung et al.
CHEST (2010)
Telangiectases in Scleroderma: A Potential Clinical Marker of Pulmonary Arterial Hypertension
Ami A. Shah et al.
JOURNAL OF RHEUMATOLOGY (2010)
Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies
Jerome Avouac et al.
JOURNAL OF RHEUMATOLOGY (2010)
Connective Tissue Disease-associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Robin Condliffe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The Three-Year Incidence of Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in a Multicenter Nationwide Longitudinal Study in France
Eric Hachulla et al.
ARTHRITIS AND RHEUMATISM (2009)
Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?
Eric Hachulla et al.
CHEST (2009)
Tadalafil Therapy for Pulmonary Arterial Hypertension
Nazzareno Galie et al.
CIRCULATION (2009)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension
Dan Hagger et al.
RHEUMATOLOGY (2009)
Pulmonary hypertension
Gorev Grubu Uyeleri et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis
Virginia Steen et al.
CHEST (2008)
The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis
C. Kampolis et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2008)
High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis
Y. Allanore et al.
ARTHRITIS AND RHEUMATISM (2008)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
R. J. Barst et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
Mark H. Williams et al.
EUROPEAN HEART JOURNAL (2006)
Early detection of pulmonary arterial hypertension in systemic sclerosis -: A French nationwide prospective multicenter study
E Hachulla et al.
ARTHRITIS AND RHEUMATISM (2005)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Ambrisentan therapy for pulmonary arterial hypertension
N Galié et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Autoantibodies in systemic sclerosis
VD Steen
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Isolated pulmonary hypertension in scleroderma
SR Cox et al.
INTERNAL MEDICINE JOURNAL (2005)
Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement
V Steen et al.
ARTHRITIS AND RHEUMATISM (2003)
Age and risk of pulmonary arterial hypertension in scleroderma
L Schachna et al.
CHEST (2003)
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
D Mukerjee et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Inhaled iloprost for severe pulmonary hypertension
H Olschewski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
DB Badesch et al.
ANNALS OF INTERNAL MEDICINE (2000)
分享论文
